Credit Suisse Ag Myriad Genetics Inc Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Myriad Genetics Inc stock. As of the latest transaction made, Credit Suisse Ag holds 98,455 shares of MYGN stock, worth $1.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

98,455

Previous 163,012 39.6%

Holding current value

$1.4 Million

Previous $3.12 Million 32.72%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$17.59 - $23.59 $1.14 Million - $1.52 Million	-64,557 Reduced 39.6%	98,455 $2.1 Million
Q4 2023 Feb 08, 2024	SELL	$13.91 - $21.32 $317,537 - $486,692	-22,828 Reduced 12.28%	163,012 $3.12 Million
Q3 2023 Nov 13, 2023	BUY	$15.99 - $23.22 $210,332 - $305,435	13,154 Added 7.62%	185,840 $2.98 Million
Q2 2023 Aug 11, 2023	BUY	$17.56 - $23.76 $416,575 - $563,658	23,723 Added 15.93%	172,686 $4 Million
Q1 2023 May 10, 2023	SELL	$15.26 - $23.75 $488,030 - $759,548	-31,981 Reduced 17.67%	148,963 $3.46 Million
Q4 2022 Feb 13, 2023	BUY	$14.51 - $20.99 $800,850 - $1.16 Million	55,193 Added 43.89%	180,944 $2.63 Million
Q3 2022 Nov 10, 2022	BUY	$18.21 - $27.88 $15,715 - $24,060	863 Added 0.69%	125,751 $2.4 Million
Q2 2022 Aug 12, 2022	SELL	$16.45 - $25.88 $249,250 - $392,133	-15,152 Reduced 10.82%	124,888 $2.27 Million
Q1 2022 May 16, 2022	SELL	$22.67 - $28.01 $832,374 - $1.03 Million	-36,717 Reduced 20.77%	140,040 $3.53 Million
Q4 2021 Feb 14, 2022	BUY	$24.13 - $32.63 $1.05 Million - $1.43 Million	43,678 Added 32.82%	176,757 $4.88 Million
Q3 2021 Nov 12, 2021	BUY	$29.97 - $36.66 $222,317 - $271,943	7,418 Added 5.9%	133,079 $4.3 Million
Q2 2021 Aug 16, 2021	SELL	$25.39 - $32.61 $233,029 - $299,294	-9,178 Reduced 6.81%	125,661 $3.84 Million
Q1 2021 May 14, 2021	SELL	$19.92 - $31.6 $1.11 Million - $1.76 Million	-55,716 Reduced 29.24%	134,839 $4.11 Million
Q4 2020 Feb 12, 2021	SELL	$12.16 - $19.77 $1.58 Million - $2.56 Million	-129,735 Reduced 40.51%	190,555 $3.77 Million
Q3 2020 Nov 13, 2020	BUY	$11.25 - $14.75 $760,207 - $996,716	67,574 Added 26.74%	320,290 $4.18 Million
Q2 2020 Aug 12, 2020	BUY	$10.69 - $16.49 $1.46 Million - $2.25 Million	136,560 Added 117.57%	252,716 $2.87 Million
Q1 2020 May 13, 2020	SELL	$9.78 - $29.53 $105,007 - $317,063	-10,737 Reduced 8.46%	116,156 $1.66 Million
Q4 2019 Feb 12, 2020	BUY	$20.93 - $35.1 $1.34 Million - $2.25 Million	63,963 Added 101.64%	126,893 $3.46 Million
Q3 2019 Nov 12, 2019	BUY	$22.08 - $47.08 $63,479 - $135,355	2,875 Added 4.79%	62,930 $1.8 Million
Q2 2019 Aug 14, 2019	BUY	$22.67 - $35.0 $80,387 - $124,110	3,546 Added 6.28%	60,055 $1.67 Million
Q1 2019 May 14, 2019	SELL	$26.93 - $34.7 $5.24 Million - $6.76 Million	-194,715 Reduced 77.51%	56,509 $1.88 Million
Q4 2018 Feb 13, 2019	BUY	$27.23 - $45.56 $1.8 Million - $3.01 Million	66,111 Added 35.71%	251,224 $7.3 Million
Q3 2018 Nov 13, 2018	BUY	$37.57 - $50.34 $4.4 Million - $5.9 Million	117,174 Added 172.47%	185,113 $8.52 Million
Q2 2018 Aug 14, 2018	SELL	$27.75 - $40.17 $4.39 Million - $6.35 Million	-158,096 Reduced 69.94%	67,939 $2.54 Million
Q1 2018 May 15, 2018	BUY	$28.83 - $41.01 $2.76 Million - $3.93 Million	95,719 Added 73.45%	226,035 $6.68 Million
Q4 2017 Feb 14, 2018	BUY	$28.45 - $37.14 $288,340 - $376,413	10,135 Added 8.43%	130,316 $4.48 Million
Q3 2017 Nov 14, 2017	SELL	$24.01 - $36.2 $1.15 Million - $1.73 Million	-47,777 Reduced 28.45%	120,181 $4.35 Million
Q2 2017 Aug 14, 2017	BUY	N/A	167,958	167,958 $4.34 Million

Others Institutions Holding MYGN

# of Institutions

227

Shares Held

92M

Call Options Held

297K

Put Options Held

20.7K

View Full List

About MYRIAD GENETICS INC

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.14B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

More about MYGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account